MEDV.F Stock Overview
A principal investment firm. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Medivolve Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.007 |
| 52 Week High | US$0.052 |
| 52 Week Low | US$0.0012 |
| Beta | 3.93 |
| 11 Month Change | 16.67% |
| 3 Month Change | 0% |
| 1 Year Change | -75.27% |
| 33 Year Change | -99.42% |
| 5 Year Change | -99.51% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| MEDV.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 14.8% | -0.1% | 1.0% |
| 1Y | -75.3% | 5.4% | 33.1% |
Return vs Industry: MEDV.F underperformed the US Healthcare industry which returned 5.4% over the past year.
Return vs Market: MEDV.F underperformed the US Market which returned 33.1% over the past year.
Price Volatility
| MEDV.F volatility | |
|---|---|
| MEDV.F Average Weekly Movement | 49.4% |
| Healthcare Industry Average Movement | 7.2% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MEDV.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: MEDV.F's weekly volatility has decreased from 118% to 49% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 25 | n/a | www.medivolve.ca |
Medivolve Inc. is a principal investment firm. It prefers to invest in healthcare technology, industrials, information technology. Medivolve Inc., formerly known as QuestCap Inc, was founded in 2005 and is based in Toronto, Canada.
Medivolve Inc. Fundamentals Summary
| MEDV.F fundamental statistics | |
|---|---|
| Market cap | US$176.98k |
| Earnings (TTM) | -US$1.92m |
| Revenue (TTM) | US$643.11k |
0.3x
P/S Ratio-0.1x
P/E RatioIs MEDV.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MEDV.F income statement (TTM) | |
|---|---|
| Revenue | CA$902.03k |
| Cost of Revenue | CA$140.32k |
| Gross Profit | CA$761.72k |
| Other Expenses | CA$3.45m |
| Earnings | -CA$2.69m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.099 |
| Gross Margin | 84.44% |
| Net Profit Margin | -298.01% |
| Debt/Equity Ratio | -9.5% |
How did MEDV.F perform over the long term?
See historical performance and comparison